Dr Christopher Jackson speaks at the Choosing Wisely Meeting & BMC Conclave about the management of resectable colorectal liver metastases (CRLM). He outlines how surgical resection remains the only potentially curative option in selected patients, but achieving optimal outcomes depends on careful patient selection, imaging and biological assessment. The discussion covers key factors such as disease volume, location and response to systemic therapy, emphasising a multidisciplinary approach. He underscores evolving strategies—such as minimally‑invasive surgery, advanced imaging and integration of systemic treatments—that help convert borderline cases into resectable ones, thereby improving survival in patients with CRLM.